RACGAP1 and familial pancreatic carcinoma: We also found that high levels of DSG2, LDHA, and RACGAP1 predicted poorer overall (Supplementary Fig. S4B) and disease-free survival in pancreatic cancer patients (Supplementary Fig. S4C), although these three genes did not all show good performance in the four validation datasets (Supplementary Fig. S5A–D).